Antisynthetase syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→Overview: Adding content to overview) |
||
| Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
Antisynthetase syndrome, an autoimmune disorder, is characterized by antibodies against aminoacyl-transfer ribonucleic acid synthetases, with features of interstitial lung disease, polymyositis, and arthritis. | |||
==Historical Perspective== | ==Historical Perspective== | ||
| Line 36: | Line 36: | ||
== Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
== Diagnosis == | ==Diagnosis== | ||
===Diagnostic Criteria=== | ===Diagnostic Criteria=== | ||
=== Symptoms === | ===Symptoms=== | ||
=== Physical Examination === | ===Physical Examination=== | ||
=== Laboratory Findings === | ===Laboratory Findings=== | ||
| Line 53: | Line 53: | ||
=== Other Diagnostic Studies === | ===Other Diagnostic Studies=== | ||
== Treatment == | ==Treatment== | ||
=== Medical Therapy === | ===Medical Therapy=== | ||
=== Surgery === | ===Surgery=== | ||
=== Prevention === | ===Prevention=== | ||
==References== | ==References== | ||
Revision as of 18:31, 22 July 2022
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S
Synonyms and keywords:
Overview
Antisynthetase syndrome, an autoimmune disorder, is characterized by antibodies against aminoacyl-transfer ribonucleic acid synthetases, with features of interstitial lung disease, polymyositis, and arthritis.